Evaluation of cardiometabolic risk factors in women with breast cancer before and after chemotherapy with doxorubicin and cyclophosphamide
Aim. To evaluate cardiometabolic risk (CMR) factors in women with breast cancer (BC) before and after chemotherapy (CT) with doxorubicin and cyclophosphamide.Material and methods. This prospective cohort study included 154 women with a median age of 43 years with newly diagnosed stage IIA-IIIB BC. T...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2025-02-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5951 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|